Faculty of Medicine Siriraj Hospital ( Site 4000)

Bangkok, Bangkok 10700

1 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) — Recruiting now
• Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) — Running, not enrolling